Clinical Trial Update: Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis

View source ↗

Summary

Biogen-sponsored clinical trial has completed comparing Avonex and Rebif to determine if they work comparably in relapsing multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Relapsing Multiple Sclerosis

Drugs mentioned

• Avonex (Interferon beta-1a)
• Rebif (interferon beta-1a)

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Status: COMPLETED